MediGene AG (MDGEF)
0.10
0.00 (0.00%)
USD |
OTCM |
Oct 02, 16:00
MediGene Net Income (Quarterly)
Net Income (Quarterly) Chart
Historical Net Income (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2019 | 0.0321M |
| September 30, 2019 | -6.341M |
| June 30, 2019 | -9.677M |
| March 31, 2019 | -6.443M |
| December 31, 2018 | -9.210M |
| September 30, 2018 | -6.169M |
| June 30, 2018 | -4.387M |
| March 31, 2018 | -4.363M |
| December 31, 2017 | -3.394M |
| September 30, 2017 | -3.779M |
| June 30, 2017 | -4.174M |
| March 31, 2017 | -3.920M |
| December 31, 2016 | -4.062M |
| September 30, 2016 | -5.942M |
| June 30, 2016 | 1.114M |
| March 31, 2016 | -1.529M |
| December 31, 2015 | -2.676M |
| September 30, 2015 | -4.935M |
| June 30, 2015 | -2.698M |
| March 31, 2015 | -4.128M |
| December 31, 2014 | -0.1412M |
| September 30, 2014 | -3.717M |
| June 30, 2014 | -1.093M |
| March 31, 2014 | -2.801M |
| December 31, 2013 | -3.477M |
| Date | Value |
|---|---|
| September 30, 2013 | -2.744M |
| June 30, 2013 | -3.112M |
| March 31, 2013 | -4.321M |
| December 31, 2012 | -9.714M |
| September 30, 2012 | -3.027M |
| June 30, 2012 | -3.452M |
| March 31, 2012 | -0.1586M |
| December 31, 2011 | -11.49M |
| September 30, 2011 | 0.1412M |
| June 30, 2011 | -3.882M |
| March 31, 2011 | -4.249M |
| September 30, 2010 | -6.337M |
| June 30, 2010 | |
| March 31, 2010 | -3.227M |
| December 31, 2009 | -9.004M |
| September 30, 2009 | -10.79M |
| June 30, 2009 | -8.684M |
| March 31, 2009 | -2.517M |
| December 31, 2008 | -7.633M |
| September 30, 2008 | -12.62M |
| June 30, 2008 | -12.18M |
| March 31, 2008 | -13.17M |
| December 31, 2007 | -14.24M |
| September 30, 2007 | -9.956M |
| June 30, 2007 | -8.300M |
Net Income Definition
Represents net income for the period and date(s) requested in local currency by default.
Net Income (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Net Income (Quarterly) Benchmarks
| InflaRx NV | -12.38M |
| BioNTech SE | -954.35M |
| Immatics NV | -72.66M |
| Arrowhead Pharmaceuticals, Inc. | -178.92M |
| Oncolytics Biotech, Inc. | -9.442M |